← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:538 | 538 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-441 | 70092-441-76 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:538 | 538 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-104 | 70092-104-36 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:538 | 538 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-109 | 73702-109-15 | Glycopyrrolate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:538 | 538 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5483 | 26436-5483-1 | Hydrocortisone; Amphotericin B; Chloramphenicol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:538 | 538 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6510 | 72934-6510-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:538 | 538 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:538 | 538 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:539 | 539 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-204 | 69852-204-45 | Benzocaine/Lidocaine/Tetracaine | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:539 | 539 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:539 | 539 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-222 | 70004-222-23 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:539 | 539 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:539 | 539 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-2 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:539 | 539 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5551 | 26436-5551-1 | Estriol; Testosterone; Estradiol; Progesterone | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:539 | 539 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-203 | 70004-203-32 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:539 | 539 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7023 | 71285-7023-1 | Heparin Sodium | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:539 | 539 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-125 | 63037-125-25 | Glycopyrrolate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:539 | 539 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-108 | 70092-108-36 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:539 | 539 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:539 | 539 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9015 | 71266-9015-5 | Glycopyrrolate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:539 | 539 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6394 | 72934-6394-2 | Hydrocortisone; Hydroquinone | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:539 | 539 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6520 | 72934-6520-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:539 | 539 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-115 | 70092-115-36 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:539 | 539 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:540 | 540 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6670 | 71266-6670-3 | Sodium Citrate and Gentamicin Solution | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:540 | 540 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:540 | 540 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:540 | 540 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:540 | 540 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-1 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:540 | 540 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0802 | 26436-0802-3 | Estriol; Testosterone; Estradiol; Progesterone | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:540 | 540 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-013 | 71449-013-32 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:540 | 540 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7022 | 71285-7022-1 | Heparin Sodium | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:540 | 540 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-638 | 70004-638-09 | Glycopyrrolate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:540 | 540 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9235 | 71266-9235-1 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:540 | 540 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:540 | 540 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9015 | 71266-9015-3 | Glycopyrrolate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:540 | 540 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6377 | 72934-6377-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:540 | 540 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6518 | 72934-6518-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:540 | 540 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-287 | 70092-287-35 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:540 | 540 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:541 | 541 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-611 | 70092-611-44 | L.E.T. Gel 3 ml in 5 ml TS | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:541 | 541 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:541 | 541 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:541 | 541 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:541 | 541 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-5 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:541 | 541 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Felis Catus Skin; Felis Catus Dander | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:541 | 541 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-9010 | 60652-9010-1 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:541 | 541 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8000 | 71285-8000-1 | Heparin Sodium | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:541 | 541 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-083 | 70092-083-44 | Glycopyrrolate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:541 | 541 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:541 | 541 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9225 | 71266-9225-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:541 | 541 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2004 | 71266-2004-9 | Glycopyrrolate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:541 | 541 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6376 | 72934-6376-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:541 | 541 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6527 | 72934-6527-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:541 | 541 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-286 | 70092-286-74 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:541 | 541 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:542 | 542 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5535 | 72934-5535-4 | Nolira | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:542 | 542 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Lidocaine Hydrochloride; Gabapentin; Tetracaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:542 | 542 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:542 | 542 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:542 | 542 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-523 | 69374-523-10 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:542 | 542 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:542 | 542 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-910 | 71170-910-25 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:542 | 542 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8100 | 72196-8100-1 | Heparin Sodium | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:542 | 542 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:542 | 542 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-399 | 70092-399-75 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:542 | 542 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9227 | 71266-9227-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:542 | 542 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:542 | 542 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6384 | 72934-6384-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:542 | 542 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6511 | 72934-6511-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:542 | 542 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:542 | 542 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:543 | 543 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-988 | 69374-988-10 | Amino Acid 50gm/1000ml | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:543 | 543 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Lidocaine Hydrochloride; Gabapentin; Tetracaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:543 | 543 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:543 | 543 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:543 | 543 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-523 | 69374-523-25 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:543 | 543 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-3020 | 70214-3020-1 | Fentanyl | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:543 | 543 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-900 | 71170-900-01 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:543 | 543 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7022 | 72196-7022-1 | Heparin Sodium | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:543 | 543 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9015 | 71266-9015-3 | Glycopyrrolate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:543 | 543 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-225 | 70092-225-37 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:543 | 543 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-105 | 70092-105-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:543 | 543 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:543 | 543 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6393 | 72934-6393-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:543 | 543 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6512 | 72934-6512-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:543 | 543 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:543 | 543 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:544 | 544 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6509 | 72934-6509-2 | Melondis | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:544 | 544 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Lidocaine Hydrochloride; Gabapentin; Tetracaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:544 | 544 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-200 | 70004-200-06 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:544 | 544 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:544 | 544 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:544 | 544 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-203 | 73702-203-02 | Fentanyl | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:544 | 544 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-202 | 70004-202-22 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:544 | 544 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7009 | 71285-7009-1 | Heparin Sodium | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:544 | 544 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9015 | 71266-9015-5 | Glycopyrrolate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:544 | 544 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-504 | 70092-504-36 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:544 | 544 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:544 | 544 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:544 | 544 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6386 | 72934-6386-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:544 | 544 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6519 | 72934-6519-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:544 | 544 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-234 | 68985-234-91 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:544 | 544 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-546 | 70092-546-35 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:545 | 545 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0102 | 70168-0102-1 | Testo100mgCHOL2 | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:545 | 545 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Lidocaine Hydrochloride; Gabapentin; Tetracaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:545 | 545 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-200 | 70004-200-16 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:545 | 545 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:545 | 545 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-910 | 71170-910-25 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:545 | 545 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-203 | 73702-203-40 | Fentanyl | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:545 | 545 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-4 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:545 | 545 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7023 | 72196-7023-1 | Heparin Sodium | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:545 | 545 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6084 | 72196-6084-1 | Glycopyrrolate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:545 | 545 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-264 | 70004-264-22 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:545 | 545 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:545 | 545 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:545 | 545 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6378 | 72934-6378-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:545 | 545 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-018 | 71449-018-32 | Hydromorphone | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:545 | 545 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-294 | 70092-294-74 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:545 | 545 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:546 | 546 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-132 | 70092-132-43 | Morphine PF 0.5 mg/ml 2 ml-3ml syr | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:546 | 546 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Lidocaine Hydrochloride; Gabapentin; Tetracaine Hydrochloride; Baclofen | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:546 | 546 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:546 | 546 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:546 | 546 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-900 | 71170-900-01 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:546 | 546 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-204 | 73702-204-40 | Fentanyl | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:546 | 546 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-1 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:546 | 546 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-281 | 70092-281-08 | Heparin Sodium | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:546 | 546 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-104 | 71449-104-11 | Glycopyrrolate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:546 | 546 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-260 | 70004-260-32 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:546 | 546 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:546 | 546 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7023 | 71285-7023-1 | Heparin Sodium | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:546 | 546 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6385 | 72934-6385-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:546 | 546 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:546 | 546 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:546 | 546 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:547 | 547 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-3 | Lidocaine HCl 1% | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:547 | 547 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Lidocaine Hydrochloride; Nifedipine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:547 | 547 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:547 | 547 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:547 | 547 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-222 | 70004-222-09 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:547 | 547 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-202 | 73702-202-02 | Fentanyl | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:547 | 547 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-5 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:547 | 547 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8100 | 71285-8100-1 | Heparin Sodium | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:547 | 547 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-109 | 73702-109-32 | Glycopyrrolate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:547 | 547 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-4272 | 60652-4272-1 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:547 | 547 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:547 | 547 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7022 | 71285-7022-1 | Heparin Sodium | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:547 | 547 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-018 | 71449-018-32 | Hydromorphone | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:547 | 547 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:547 | 547 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:547 | 547 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:548 | 548 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-610 | 81375-610-03 | Tirzepatide | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:548 | 548 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Lidocaine Hydrochloride; Nifedipine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:548 | 548 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-4 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:548 | 548 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-9010 | 60652-9010-1 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:548 | 548 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-222 | 70004-222-04 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:548 | 548 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-202 | 73702-202-03 | Fentanyl | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:548 | 548 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-200 | 70004-200-06 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:548 | 548 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-95 | Heparin Sodium | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:548 | 548 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2004 | 71266-2004-8 | Glycopyrrolate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:548 | 548 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-677 | 70324-677-01 | Fentanyl; Bupivacaine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:548 | 548 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:548 | 548 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8000 | 71285-8000-1 | Heparin Sodium | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:548 | 548 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-117 | 73177-117-28 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:548 | 548 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:548 | 548 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-290 | 70092-290-49 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:548 | 548 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:549 | 549 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2101 | 72627-2101-3 | Testosterone Cypionate | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:549 | 549 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Methocarbamol; Dexamethasone | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:549 | 549 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-3 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:549 | 549 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-523 | 69374-523-25 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:549 | 549 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-222 | 70004-222-30 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:549 | 549 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:549 | 549 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-200 | 70004-200-16 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:549 | 549 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-91 | Heparin Sodium | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:549 | 549 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2004 | 71266-2004-9 | Glycopyrrolate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:549 | 549 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73217-006 | 73217-006-50 | Fluorouracil | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:549 | 549 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-500 | 70092-500-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:549 | 549 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7009 | 71285-7009-1 | Heparin Sodium | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:549 | 549 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-117 | 73177-117-27 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:549 | 549 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:549 | 549 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5055 | 71266-5055-2 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:549 | 549 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5035 | 71266-5035-1 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:550 | 550 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5601 | 26436-5601-5 | Trimix 40/30/4 | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:550 | 550 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Niacinamide | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:550 | 550 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2001 | 71286-2001-3 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:550 | 550 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2081 | 71286-2081-1 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:550 | 550 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-200 | 70004-200-06 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:550 | 550 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:550 | 550 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-200 | 70004-200-17 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:550 | 550 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0421 | 71285-0421-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:550 | 550 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6084 | 71286-6084-1 | Glycopyrrolate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:550 | 550 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-013 | 79926-013-03 | Flurbiprofen Sodium | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:550 | 550 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:550 | 550 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8100 | 71285-8100-1 | Heparin Sodium | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:550 | 550 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:550 | 550 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:550 | 550 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:550 | 550 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9115 | 71266-9115-1 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:551 | 551 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7016 | 71285-7016-1 | Potassium Phosphate 30mmol added to NS | 2026-1 | valid | 0 | 2026-09-18 |